Rapidly Identify Individuals at High Risk of Addiction
The Ohio Opioid Technology Challenge is a three-phase prize competition that seeks to accelerate the development and deployment of innovative technology solutions that address the opioid crisis through addiction prevention and treatment, and overdose avoidance and response.
The Challenge Phase consists of four Challenge Topics that address specific unmet needs or concerns related to opioid use, abuse and exposure. Topic 1 seeks solutions that rapidly identify individuals at high risk of addiction
Persons become involved with the use of opioids by a variety of pathways—receiving a prescription to address pain after injury or surgery or to manage chronic pain, using illicit drugs, providing patient care as a clinician or first responder.
One way to address addiction is to understand whether a person who is a candidate to receive an opioid has a predisposition to become an addict. If a physician could administer a diagnostic to understand the risk for addiction before prescribing opioids, then he/she could consider alternative methods of treatment for those at high risk of addiction.
About the Challenge
NineSigma, on behalf of the State of Ohio, seeks challenge responses which Rapidly Identify Individuals at High Risk of Addiction.
Responses should be solutions already in development, focused specifically on the Topic. Responses could include but are not limited to: physiological or genetic diagnostic technologies, diagnostic questionnaire (paired with novel technology), or analysis algorithms.
The Challenge Phase will conclude by awarding up to twelve (12) $200,000 prizes across the four Topics. Prize Recipients of the Challenge Phase will be eligible to compete in the final, Product Phase of the Challenge with prizes of $1 million or more.
GENERAL EVALUATION CRITERIA FOR ALL CHALLENGE TOPICS:
Responses should consider:
How your approach aligns with Key Attributes for the Topic for which you are submitting an Entry
Technology maturity and time to market
For similar approaches, preference will be given to the one that is more mature and/or that has a shorter time to market
Potential for broad deployment or implementation
Size/scope of audience impacted (“market size”)
KEY ATTRIBUTES FOR TOPIC 1 DIAGNOSE:
Your approach should:
Enable identification of a person’s risk of addiction
Offer clear interpretation or signaling
Offer concrete evidence that demonstrates efficacy
Be effective in as short a time as possible
Have low occurrence of false events
Be easy to implement and use (from a patient and/or clinician perspective)